[GAMUDA] QoQ TTM Result on 31-Jul-2011 [#4]

Stock
[GAMUDA] GAMUDA BHD
Announcement Date
29-Sep-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2011
Quarter
31-Jul-2011 [#4]
Profit Trend
QoQ- 10.23%
YoY- 31.74%
Quarter Report
Latest QR
Upcoming QR
GAMUDA's Result
GAMUDA's Financial Summary
View:
Show?
TTM Result
30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 CAGR
Revenue 2,927,795 2,843,136 2,681,000 2,673,208 2,577,377 2,467,373 2,463,423 12.21%
PBT 702,599 664,940 601,994 544,524 508,589 452,008 427,455 39.31%
Tax -150,910 -138,026 -125,415 -111,579 -114,610 -90,700 -82,328 49.83%
NP 551,689 526,914 476,579 432,945 393,979 361,308 345,127 36.75%
-
NP to SH 533,026 511,646 469,198 425,411 385,918 352,817 337,425 35.67%
-
Tax Rate 21.48% 20.76% 20.83% 20.49% 22.53% 20.07% 19.26% -
Total Cost 2,376,106 2,316,222 2,204,421 2,240,263 2,183,398 2,106,065 2,118,296 7.96%
-
Net Worth 3,984,736 3,825,379 3,818,879 3,691,757 3,640,924 3,564,346 3,561,632 7.77%
Dividend
30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 CAGR
Div 248,378 247,276 247,276 245,534 230,270 227,896 227,896 5.91%
Div Payout % 46.60% 48.33% 52.70% 57.72% 59.67% 64.59% 67.54% -
Equity
30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 CAGR
Net Worth 3,984,736 3,825,379 3,818,879 3,691,757 3,640,924 3,564,346 3,561,632 7.77%
NOSH 2,075,383 2,067,772 2,064,259 2,062,434 2,057,019 2,048,474 2,035,218 1.31%
Ratio Analysis
30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 CAGR
NP Margin 18.84% 18.53% 17.78% 16.20% 15.29% 14.64% 14.01% -
ROE 13.38% 13.38% 12.29% 11.52% 10.60% 9.90% 9.47% -
Per Share
30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 CAGR
RPS 141.07 137.50 129.88 129.61 125.30 120.45 121.04 10.75%
EPS 25.68 24.74 22.73 20.63 18.76 17.22 16.58 33.90%
DPS 12.00 12.00 12.00 12.00 11.25 11.25 11.25 4.40%
NAPS 1.92 1.85 1.85 1.79 1.77 1.74 1.75 6.38%
Adjusted Per Share Value based on latest NOSH - 2,062,434
30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 CAGR
RPS 105.61 102.55 96.71 96.42 92.97 89.00 88.86 12.21%
EPS 19.23 18.46 16.92 15.34 13.92 12.73 12.17 35.70%
DPS 8.96 8.92 8.92 8.86 8.31 8.22 8.22 5.92%
NAPS 1.4373 1.3798 1.3775 1.3316 1.3133 1.2857 1.2847 7.77%
Price Multiplier on Financial Quarter End Date
30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 CAGR
Date 30/04/12 31/01/12 31/10/11 29/07/11 29/04/11 31/01/11 29/10/10 -
Price 3.56 3.70 3.40 3.69 3.74 3.81 3.80 -
P/RPS 2.52 2.69 2.62 2.85 2.98 3.16 3.14 -13.65%
P/EPS 13.86 14.95 14.96 17.89 19.93 22.12 22.92 -28.51%
EY 7.21 6.69 6.69 5.59 5.02 4.52 4.36 39.88%
DY 3.37 3.24 3.53 3.25 3.01 2.95 2.96 9.04%
P/NAPS 1.85 2.00 1.84 2.06 2.11 2.19 2.17 -10.09%
Price Multiplier on Announcement Date
30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 CAGR
Date 28/06/12 28/03/12 16/12/11 29/09/11 23/06/11 24/03/11 17/12/10 -
Price 3.46 3.60 3.00 2.87 3.75 3.79 3.83 -
P/RPS 2.45 2.62 2.31 2.21 2.99 3.15 3.16 -15.61%
P/EPS 13.47 14.55 13.20 13.91 19.99 22.00 23.10 -30.22%
EY 7.42 6.87 7.58 7.19 5.00 4.54 4.33 43.24%
DY 3.47 3.33 4.00 4.18 3.00 2.97 2.94 11.69%
P/NAPS 1.80 1.95 1.62 1.60 2.12 2.18 2.19 -12.26%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment